Aptiv Solutions Executive Discusses the State of Mobile Health Technology Regulatory

OneMedRadio spoke with Cynthia Nolte, Director, Medical Device Regulatory Services for Aptiv Solutions, about the state of mobile health/health information technology regulatory, clinical trial design for mobile health technology, and what we can expect from future guidelines. The conclusions about regulating a rapidly evolving space — and the case studies that have pioneered this process — are intriguing, and indeed promising.

Read more »

Bioinformatics Part II: Application, Manipulation, and Uses

Or, How I Learned to Stop Worrying and Love Computational Biology.

Read more »

ReCor Medical: Renal Denervation, and a New Approach to Reducing High Blood Pressure

What if there was a way to substantially reduce high blood pressure for patients who have tried everything? Renal denervation is a hot topic, and ReCor Medical offers a unique ultrasound approach to enhance this exciting therapy…

Read more »

Jack Young, Qualcomm Life Sciences Director, Discusses Mobile Health and Patient Management

Young’s experience in both sectors makes him a unique voice in the osmosis of venture capital between mobile technology and life sciences. Young will participate in a panel dedicated to the subject at the 6th Annual OneMedForum in San Francisco, January 7-9. OneMedRadio spoke with Jack Young about investing in this sector, and the points of significant unmet medical need which represent the most promising opportunities.

Read more »

`OneMedForum` Panel to Address the Major Opportunities in Digital Health at San Francisco Conference

OneMedPlace announced today that Peter Neupert of Health Evolution Partners and Jack Young of Qualcomm Ventures will participate in programming for the 6th Annual OneMedForum, January 7-9, 2013, in San Francisco. The two experts will take part in a panel dedicated to ‘Digital and Connected Health,’ an emerging sector with significant and diverse investment opportunities.

Read more »

OneMedRadio: DARA BioSciences CEO on Oncology Market Opportunity, Key Catalysts

In Part II of our discussion with DARA Biosciences (NASDAQ: DARA) CEO and Chief Medical Officer Dr. David Drutz, we look into key catalysts for the specialty pharmaceutical company. Dr. Drutz discusses the medical need for the oral-liquid tamoxifen, Soltamox, licensed to DARA by UK-based Rosemont Pharmaceuticals — as well as the market opportunity in developing oncology services.

Read more »

OneMedRadio: Healthtech Conference 2012 — What to Watch For

HealthTech Conference 2012, on October 26th in San Francisco, is a single day summit covering the most important issues in this burgeoning sector. OneMedRadio spoke with Anne Degheest, Managing Director and Founder of HealthTech Capital, about conference programming, and the unique investment opportunity in the sector.

Read more »

Press Release: 3rd Annual Medtech Summit to Showcase Nearly 100 Companies

OneMedPlace will be covering the European Tech Tour Association’s 3rd Annual Medtech Summit, taking place October 16-17 in Lausanne, Switzerland. Stay tuned for on-site coverage of programming and showcased companies, as well as a wrap-up of the event!

Read more »

OneMedRadio: AdvaMed 2012 — What to Watch For

OneMedRadio spoke with Ray Briscuso, Managing Partner and Producer of AdvaMed 2012, to learn about the can’t miss highlights in conference programming. Briscuso also discussed the history of the conference — how a gathering once geared toward trade association types has grown into one of the most important events in facilitating growth company finance in the sector.

Read more »

AdvaMed 2012: The MedTech Sector Event of the Year

The 6th Annual AdvaMed 2012 MedTech Conference kicks off October 1st for a 3-day event covering the hottest issues in the sector. This year, AdvaMed expects more than 2,100 attendees, 800 MedTech companies from 24 countries, 36 states and DC.

Read more »